1. Home
  2. FBYD vs CBLL Comparison

FBYD vs CBLL Comparison

Compare FBYD & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Falcon's Beyond Global Inc.

FBYD

Falcon's Beyond Global Inc.

HOLD

Current Price

$4.37

Market Cap

821.0M

Sector

N/A

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$20.42

Market Cap

865.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBYD
CBLL
Founded
2021
2014
Country
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
821.0M
865.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FBYD
CBLL
Price
$4.37
$20.42
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$24.67
AVG Volume (30 Days)
127.1K
284.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$37.44
Revenue Next Year
N/A
$27.72
P/E Ratio
$268.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$10.01
52 Week High
$29.02
$26.04

Technical Indicators

Market Signals
Indicator
FBYD
CBLL
Relative Strength Index (RSI) 36.07 46.87
Support Level $3.71 $19.49
Resistance Level $5.09 $20.72
Average True Range (ATR) 0.75 1.08
MACD 0.21 -0.09
Stochastic Oscillator 28.20 47.32

Price Performance

Historical Comparison
FBYD
CBLL

About FBYD Falcon's Beyond Global Inc.

Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.

About CBLL CeriBell Inc.

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: